0001179110-19-011615.txt : 20191112 0001179110-19-011615.hdr.sgml : 20191112 20191112162157 ACCESSION NUMBER: 0001179110-19-011615 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191107 FILED AS OF DATE: 20191112 DATE AS OF CHANGE: 20191112 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KWON YOUNG CENTRAL INDEX KEY: 0001733094 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50797 FILM NUMBER: 191209816 MAIL ADDRESS: STREET 1: C/O MOMENTA PHARMACEUTICALS INC. STREET 2: 675 WEST KENDALL STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MOMENTA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001235010 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043561634 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617 491-9700 MAIL ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 edgar.xml FORM 4 - X0306 4 2019-11-07 0 0001235010 MOMENTA PHARMACEUTICALS INC MNTA 0001733094 KWON YOUNG C/O MOMENTA PHARMACEUTICALS, INC. 301 BINNEY STREET CAMBRIDGE MA 02142 0 1 0 0 SVP, Chief Business Officer Common Stock 2019-11-07 4 M 0 1410 A 109864 D Common Stock 2019-11-08 4 S 0 632 16.06 D 109232 D Restricted Stock Units 2019-11-07 4 M 0 1410 0 D Common Stock 1410 7047 D Shares received pursuant to settlement of Restricted Stock Units that were granted on February 7, 2017. This transaction was effected pursuant to a Rule 10b5-1 trading plan. Restricted Stock Units convert into common stock on a one-for-one basis. Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years. /s/ R. Mark Chamberlin as attorney in fact 2019-11-12